Figure 6.
HDAC4 degradation in Jurkat E6-1 cells upon treatment with compounds 7 and 11 dosed at 1 μM and 100 nM, respectively, compared to DMSO control in the presence and absence of 1 μM proteasome inhibitors MG132 orcarfilzomib after 6 h.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.